Drug Profile
Safironil
Alternative Names: Hoe 277Latest Information Update: 09 Jul 2002
Price :
$50
*
At a glance
- Originator Aventis
- Class
- Mechanism of Action Procollagen-proline dioxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatic fibrosis
Most Recent Events
- 29 Dec 1999 Hoechst Marion Roussel has merged with Rhône-Poulenc Rorer to form Aventis Pharma
- 24 Nov 1998 Investigation in Hepatic fibrosis in USA (Unknown route)
- 06 Sep 1996 Phase-I clinical trials for Cirrhosis in Germany (Unknown route)